Biorx Venture Advisors Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-07-2024
- Paid Up Capital ₹ 0.50 M
as on 09-07-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -40.65%
(FY 2021)
- Profit 49.90%
(FY 2021)
- Ebitda 47.50%
(FY 2021)
- Net Worth -19.05%
(FY 2021)
- Total Assets -18.06%
(FY 2021)
About Biorx Venture Advisors
The Company is engaged in the Finance And Insurance Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Dau Bansal, Dinesh Sharma, Pritika Kalra, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74140DL2011PTC218769
- Company No.
218769
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biorx Venture Advisors Private Limited offer?
Biorx Venture Advisors Private Limited offers a wide range of products and services, including Financial Service, Private Equity Services, Business Consultant, Joint Venture Consultants, Sell-Side Advisory Services, Structured Finance Service, Finance Consultant.
Who are the key members and board of directors at Biorx Venture Advisors?
Executive Team (1)
Vishal Gandhi
Managing DirectorAppointment Date: 06-May-2011
Status: Current
Board Members(4)
Financial Performance and Corporate Structure Insights of Biorx Venture Advisors.
Biorx Venture Advisors Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 40.65% decrease. The company also saw a substantial improvement in profitability, with a 49.9% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biorx Venture Advisors?
In 2021, Biorx Venture Advisors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
2 years 10 months 
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biorx Venture Advisors?
Unlock and access historical data on people associated with Biorx Venture Advisors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Apr 29, 2015, Biorx Venture Advisors has raised a total of ₹ 0.8 M, with the most recent deal valued at ₹ 0.4 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
